AtriCure, Inc.
AtriCure, Inc. (ATRC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATRC · as of Jun 8, 2026
Key Statistics
Explore AtriCure, Inc. Data
atrc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 94.7%
The ATRC analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $51.33, representing +90.32% upside from the current price of $26.97.
Competitors & Peers
atrc competitorsATRC
AZTA
BLFS
IMCR
KMTS
LMATStock Performance
Full HistoryAbout AtriCure, Inc.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and inte…
what is atricure, inc. · atrc stock overview · atricure, inc. company profile · who is atricure, inc. ceo · atrc NASDAQ · atricure, inc. headquarters · atricure, inc. business segments
About Stock Overview & Key Data
AtriCure, Inc. (ATRC) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Aug 5, 2005. As of the latest trading session, ATRC stock price is $26.97, with a market capitalization of $1.4B. The stock has returned -21.26% over the past 12 months and -31.96% year-to-date.
According to 19 Wall Street analysts, the consensus rating for AtriCure, Inc. stock is Buy, with an average 12-month price target of $51.33. In fiscal year 2025, AtriCure, Inc. reported revenue of $534.5M and net income of -$11.4M. For detailed data — including AtriCure, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AtriCure, Inc. (ATRC) stock price is $26.97. The stock is traded on NASDAQ under the ticker symbol ATRC. The 52-week range is $25.36 – $43.18.